Percutaneous transcatheter valve therapy;Terapéutica valvular percutánea

Revista Espanola de Cardiologia

Volumn 61, Issue SUPPL. 2, 2008, Pages 10-24

  Chiam, Paul T L ^a   Del Valle Fernández, Raquel ^a   Ruiz, Carlos E ^a,b  

^a LENOX HILL HEART AND VASCULAR INSTITUTE   (United States)

^b Blackhall   (United States)

Author keywords

Aortic valve stenosis; Mitral regurgitation; Percutaneous treatment; Valvular prosthesis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYPOTENSION; MITRAL VALVE PROSTHESIS; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE REPLACEMENT; NANOTECHNOLOGY; PATIENT SELECTION; PECUTANEOUS AORTA VALVE REPLACEMENT; PECUTANEOUS MITRAL VALVE REPLACEMENT; REVIEW; TISSUE ENGINEERING; AORTA VALVE; AORTA VALVE STENOSIS; ARTICLE; FORECASTING; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; METHODOLOGY; MITRAL VALVE; PROSTHESIS;

AORTIC VALVE; AORTIC VALVE STENOSIS; FORECASTING; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PROSTHESIS DESIGN;

EID: 54549107821     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13114951     Document Type: Editorial

References (61)

1. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231-43.
2. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106: 3006-8.
3. Feldman T, Wasserman HS, Herrmann HC, Gray W, Block PC, Whitlow P, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol. 2005;46:2134-40.
4. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005-11.
5. Society of Thoracic Surgeons National Cardiac Surgery Database [citado 26 Dic 2007]. Disponible en: http://www.sts.org/documents/pdf/Spring2005STS- ExecutiveSummary.pdf
6. US Census Bureau. United States Census 2000. Washington: US Census Bureau; 2001.
7. Culliford AT, Galloway AC, Colvin SB, Grossi EA, Bowmann FG, Esposito R, et al. Aortic valve replacement for aortic stenosis in persons aged 80 years and over. Am J Cardiol. 1991;67:1256-60.
8. Kvidal P, Bergstrom R, Horte LG, Stahle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol. 2000;35:747-56.
9. Astor BC, Kaczmarek RG, Hefflin B, Daley WR. Mortality after aortic valve replacement: results from a nationally representative database. Ann Thorac Surg. 2000;70:1939-45.
10. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas L, Batista I, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346:1128-37.
11. Burr LH, Jamieson WR, Munro AI, Miyagishima RT, Germann E. Porcine bioprostheses in the elderly: clinical performance by age groups and valve positions. Ann Thorac Surg. 1995;60:S264-9.
12. Roques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE. Eur Heart J. 2003;24:881-2.
13. Edwards FH, Grover FL, Shroyer AL, Schwartz M, Bero J. The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. Ann Thorac Surg. 1997;63:903-8.
14. Kvidal P, Bergstrom R, Malm T, Stahle E. Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur Heart J. 2000;21:1099-111.
15. Roques F, Nashef SA, Michel P. Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. J Heart Valve Dis. 2001;10:572-7.
16. Logeais Y, Langanay T, Roussin R, Leguerrier A, Rioux C, Chaperon J, et al. Surgery for aortic stenosis in elderly patients. A study of surgical risk and predictive factors. Circulation. 1994;90:2891-8.
17. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26:2714-20.
18. Pai RG, Kapoor N, Bansal RC, Varadarajan P. Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann Thorac Surg. 2006;82:2116-22.
19. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J. 1992;13:704-8.
20. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004;43:698-703.
21. Grube E, Laborde JC, Gerckens U, Felderhott I, Sauren B, Buellsteld L, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation. 2006;114:1616-24.
22. Grube E, Laborde JC, Zickmann B, Gerckens U, Felderhott I, Sauren B, et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv. 2005;66:465-9.
23. Hanzel GS, Harrity PJ, Schreiber TL, O'Neill WW. Retrograde percutaneous aortic valve implantation for critical aortic stenosis. Catheter Cardiovasc Interv. 2005;64:322-6.
24. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113:842-50.
25. Grube E, Schuler G, Buellesfeld L, Gerckens V, Linke A, Wenaweser P, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69-76.
26. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, et al. Percutaneous Transarterial Aortic Valve Replacement in Selected High-Risk Patients With Aortic Stenosis. Circulation. 2007;116;755-763.
27. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006;47:1214-23.
28. Lichtenstein SV, Cheung A, Ye J, Thompson CR, Carere R, Pasupati S, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation. 2006;114:591-6.
29. Walther T, Falk V, Borger MA, Dewey T, Wimmer-Greinecker G, Schuler G, et al. Minimally invasive transapical beating heart aortic valve implantation - proof of concept. Eur J Cardiothorac Surg. 2007;31:9-15.
30. Walther T, Simon P, Dewey T, Wimmer-Greinecker G, Falk V, Kasimir MT, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation. 2007;116:I240-5.
31. Ruiz CE, Laborde JC, Condado JF, Chiam PT, Condado JA. First percutaneous transcatheter aortic valve-in-valve implant with three year follow up. Catheter Cardiovasc Interv. 2008 [en prensa].
32. Wenaweser P, Buellesfeld L, Gerckens U, Grube E. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the Corevalve Revalving system. Catheter Cardiovasc Interv. 2007;70:760-4.
33. Paniagua D, Condado JA, Besso J, Vélez M, Burger B, Bibbo S, et al. First human case of retrograde transcatheter implantation of an aortic valve prosthesis. Tex Heart Inst J. 2005;32:393-8.
34. Buellesfeld L, Gerckens U, Grube E. Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis. Catheter Cardiovasc Interv. 2008;71:579-84.
35. Zegdi R, Khabbaz Z, Borenstein N, Fabiani JN. A repositionable valved stent for endovascular treatment of deteriorated bioprostheses. J Am Coll Cardiol. 2006;48:1365-8.
36. Gammie JS, O'Brien SM, Griffith BP, Ferguson TB, Peterson ED. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation. 2007;115:881-7.
37. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48:e1-148.
38. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352:875-83.
39. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation. 1995;91:1022-8.
40. Gillinov AM, Wierup PN, Blackstone EH, Bishay ES, Cosgrove DM, White J, et al. Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg. 2001;122:1125-41.
41. Greelish JP, Cohn LH, Leacche M, Mitchell M, Karavas A, Fox J, et al. Minimally invasive mitral valve repair suggests earlier operations for mitral valve disease. J Thorac Cardiovasc Surg. 2003;126:365-71.
42. Nifong LW, Chu VF, Bailey BM, Maziarz DM, Sorrell VL, Holbert D, et al. Robotic mitral valve repair: experience with the da Vinci system. Ann Thorac Surg 2003;75:438-42.
43. Schroeyers P, Wellens F, De Geest R, Degrieck I, Van Praet F, Vermeulen Y, et al. Minimally invasive video-assisted mitral valve repair: short and mid-term results. J Heart Valve Dis. 2001;10:579-83.
44. Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Détaint D, Vanoverschelde JL, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28:1358-65.
45. Detaint D, Sundt TM, Nkomo VT, Scott CG, Tajik AJ, Schaff HV, et al. Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements. Circulation. 2006;114:265-72.
46. Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, McGoon MD, Bailey KR, et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol. 1994;24:1536-43.
47. Alfieri O, Maisano F, De Bonis M, Stefano PL, Torracca L, Oppizzi M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg. 2001;122:674-81.
48. Dang NC, Aboodi MS, Sakaguchi T, Wasserman HS, Argenziano M, Cosgrove DM, et al. Surgical revision after percutaneous mitral valve repair with a clip: initial multicenter experience. Ann Thorac Surg. 2005;80:2338-42.
49. Feldman T. Percutaneous mitral valve repair. J Interv Cardiol. 2007;20:488-94.
50. Naqvi TZ, Buchbinder M, Zarbatany D, Logan J, Molloy M, Balke G, et al. Beating-heart percutaneous mitral valve repair using a transcatheter endovascular suturing device in an animal model. Catheter Cardiovasc Interv. 2007;69:525-31.
51. Bolling SF. Mitral reconstruction in cardiomyopathy. J Heart Valve Dis. 2002;11 Suppl 1:S26-31.
52. Otto CM. Timing of surgery in mitral regurgitation. Heart. 2003;89:100-5.
53. Duffy SJ, Federman J, Farrington C, Reuter DG, Richardson M, Kaye DM. Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of functional mitral regurgitation in patients with heart failure. Catheter Cardiovasc Interv. 2006;68:205-10.
54. Schofer J. The Carillon Experience (presented at EuroPCR 2007). May 24 2007.
55. Dubreuil O, Basmadjian A, Ducharme A, Thibault B, Crepeau J, Lam JY, et al. Percutaneous mitral valve annuloplasty for ischemic mitral regurgitation: first in man experience with a temporary implant. Catheter Cardiovasc Interv. 2007;69:1053-61.
56. Webb JG, Harnek J, Munt BI, Kimblad PO, Chandavimol M, Thompson CR, et al. Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus. Circulation. 2006;113:851-5.
57. Harnek J. The Monarc Experience (presented at EuroPCR 2007). May 24 2007.
58. Maselli D, Guarracino F, Chiaramonti F, Mangia F, Borelli G, Minzioni G. Percutaneous mitral annuloplasty: an anatomic study of human coronary sinus and its relation with mitral valve annulus and coronary arteries. Circulation. 2006;114:377-80.
59. Choure AJ, Garcia MJ, Hesse B, Sevensma M, Maly G, Greenberg NL, et al. In vivo analysis of the anatomical relationship of coronary sinus to mitral annulus and left circumflex coronary artery using cardiac multidetector computed tomography: implications for percutaneous coronary sinus mitral annuloplasty. J Am Coll Cardiol. 2006;48:1938-45.
60. Palacios IF, Condado JA, Brandi S, Rodriguez V, Bosch F, Silva G, et al. Safety and feasibility of acute percutaneous septal sinus shortening: first-in-human experience. Catheter Cardiovasc Interv. 2007;69:513-8.
61. Grossi EA, Saunders PC, Woo YJ, Gangahar DM, Laschinger JC, Kress DC, et al. Intraoperative effects of the coapsys annuloplasty system in a randomized evaluation (RESTOR-MV) of functional ischemic mitral regurgitation. Ann Thorac Surg. 2005;80:1706-11.